Excellent summary of inflammatory breast conditions that are 🦓 🦓 🦓 by Carinne Anderson, MD, FACS! #ASBrS24 ASBrS

Very nice overview of a challenging diagnosis - idiopathic granulomatous mastitis - by Sarah L. Blair #ASBrS24 ASBrS

As always impressed by Chandler S Cortina, MD’s work on breast cancer risk assessment & screening for transgender persons…a very important topic that needs more awareness and research! #ASBrS24 ASBrS MCW Surgery MCW Cancer Center

Dr. Rojas busts myths around #oncofertility in breast cancer

Not only can fertility preservation be safely offered to women with breast cancer, it does not increase time to treatment.

#asbrs24

Beautiful venue for the #ASBrS24 President’s Reception! ASBrS

Congratulations to winners of the top presentations and poster winners #ASBrS24 !!! ASBrS

Wonderful presentation of surgical outcomes from KEYNOTE-756 (pembro for ERpos breast cancer) ASBrS #ASBrS24

Congrats to all of the winners!! Very proud of our MD Anderson Cancer Center breast surgical oncology fellow Dr. Alex Moore for her impressive work and for winning the George Peters Award!! #oncsurgery #endcancer #ASBrS24 ASBrS

#ASBrS24

Thanks for sharing Robyn Roth MD | Breast Radiologist 🩻!

Great study using REQUITE database for QoL outcomes for women over 70 with breast cancer: choice of endocrine therapy matters ⁦ASBrS⁩ #ASBrS24

Great talk by Dr rosencranz about patient selection for repeat breast conservation! #asbrs24 @asbrs

.Keva Li presents on differences in HRQoL between different endocrine therapies in patients >= 70 yrs #ASBrS24 ASBrS

Excellent presentation by ⁦Mara Piltin⁩ ⭐️ Internal mammary lymphadenopathy does NOT impact oncologist outcome in pts treated with NAC from ⁦I-SPY 2⁩ ⁦👇🏼👇🏼👇🏼ASBrS⁩ #asbrs24

Great study by ⁦Mara Piltin⁩ from I-SPY demonstrating internal mammary lymph node involvement in breast cancer not poor prognostic indicator with multidisciplinary management ⁦ASBrS⁩ #ASBrS24

Data from ispy2 shows IM lymphadenopathy in patients treated with neoadjuvant chemotherapy does not negatively impact outcome. #asbrs24 ⁦I-SPY 2⁩ Mara Piltin⁩ ⁦Mayo Clinic Department of Surgery⁩ ⁦Mayo Clinic Comprehensive Cancer Center⁩

.Mara Piltin presents data on IM nodal positivity & outcomes from the I-SPY2 trial #ASBrS24 ASBrS Mayo Clinic Department of Surgery Judy Boughey

Great ASBrS survey study by ⁦Dr. Nimmi Kapoor⁩ about Granulomatous Mastitis and algorithm for treatment #ASBrS24

Great updates from SABCS ASCO ASTRO by Shelley Hwang Kelly K Hunt Julia White. So many practice changing studies to improve care for breast cancer! ASBrS #asbrs24

Theme of the “Best of” session seems to be de-escalation across SABCS, ASCO, and ASTRO. Much thanks to Shelley Hwang Kelly K Hunt, and Dr. Julia White for providing excellent summaries of these practice changing trials. ASBrS #ASBrS24